Acute Toxicants
Acute Toxicity, Category 1 and 2: (including GHS # H300, H310, H330) Cyanides [hydrogen cyanide, cyanide salts, metal cyanides] Cyanogens [including cyanogen bromide] Osmium Tetroxide Hydrogen Fluoride (Hydrofluoric Acid) Alkyl mercury derivatives [including dimethyl mercury] Dimethyl sulfate Tetranitromethane N-Nitrosodimethylamine α-Naphthylamine Methyl chloromethyl ether β-Propiolactone Dioxins, Furans, and Dioxin-Like Polychlorinated Biphenyls Nickel carbonyl Organotins [including tributyltin] […]
Water-Reactives
Water-Reactive Chemicals, Category 1: (including GHS # H260) Lithium Potassium Rubidium Cesium Sodium Lithium Aluminum Hydride Potassium Hydride Sodium Hydride Lithium_CC zzPotassium_CC Rubidium_CW Cesium_CC zzSodium_CC Lithium Aluminum Hydride_ethereal_CW SOP_Lithium_Aluminum_Hydride_09_13_2012 (post_RV) (2) SOP for Potassium Hydride SOP for Sodium Hydride
Exposives & Self-Reactives
Explosives: (including GHS # H200, H201, H202, H203, H204, H205) Ammonium Perchlorate Perchloric Acid (>72%) and Inorganic Perchlorate Salts Ammonium Perchlorate 08-22-2012 zzPerchlorate salts_CC Perchloric acid SOP UNC- Lab Manual – Explosives Self-Reactive Substances, Type A: (including GHS # H251) Zirconium, finely powdered Zirconium Powder_CW
Appendix P: ROHP Medical Surveillance Program
BU provides medical monitoring to all employees who face workplace risks. The program is designed to monitor potential health hazards associated with research and development activity with recombinant DNA, bloodborne pathogens, other etiologic agents, zoonotic diseases associated with laboratory animals, and hazardous chemicals. The details of the program are provided below: Objectives and Scope The Medical […]
Appendix G: List of Biological Agents with the Potential to Cause Laboratory Acquired Infection (LAI)
The List of Biological Agents with the Potential to Cause Laboratory Acquired Infection (LAI) contains BSL4, BSL3, BSL4 and BSL2 agents in use within the research community. Principal Investigators and research staff listed on approved IBC protocols involving these biological agents with the potential to cause LAI must receive agent specific training, agent specific identification […]
Appendix F: Guidelines for Work with Toxins of Biological Origin
Biological toxins are poisons, either naturally produced by living organisms including animals, plants, or microbial sources that cause death or severe incapacitation at relatively low exposure levels. Biological toxins do not replicate and are not infectious. In amounts used most typically in biomedical research laboratories, biological toxins can be handled safely by trained laboratory personnel […]
Appendix A: Importation and Exportation of Infectious Biological Agents
Multidisciplinary and multi-institutional research is a common practice that involves collaboration among faculty from various institutions and countries. At times it is necessary to share biological samples or materials with collaborators. Federal regulations strictly control the importation and exportation of infectious biological agents, equipment and technologies used for study and processing of these agents. The […]
Radiation Safety Committee Charter
Approved: December 11, 2020 Boston University (BU) and Boston Medical Center (BMC) are committed to providing support and services to ensure that the Radiation Safety Program is adequately staffed and properly managed; to maintaining a healthy and safe environment for students, patients, faculty, clinicians, staff, visitors, and neighbors; and to fostering a culture of safety […]
Training and Health Clearance Requirements
Training and Health Clearance Requirements Original Date Approved: 2011 Revised: 5/17/16 Next Review Date: May 2019 Purpose Boston University (BU) is committed to observing federal, state, and local regulations and the National Institute of Health (NIH) Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. The purpose of this policy is to set forth […]
Responsibility of the Principal Investigator
The following is the responsibility of the principal investigator for personnel with potential exposure to bloodborne pathogens and other potentially infectious material and other research-related occupational health issues. As a Principal Investigator (PI), your responsibility is to make sure that your research project is carried out with maximum safety considerations. This notice is to inform […]